{
  "docId": "019de075-f745-744d-a2c3-62fcecd316e9",
  "docSlug": "352ee416e6a97a9b39e1309fafdab0f3",
  "documentTitle": "Genelux | Investor Presentation Deck | 38 slides",
  "authorId": "genelux",
  "authorName": "Genelux",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 37,
  "pageCount": 38,
  "prevPage": 36,
  "nextPage": 38,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a combination of a bar chart (ELISPOT data) and a line chart (SLD over time) to show clinical efficacy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/37",
  "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9",
  "deckJsonHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9.json",
  "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-37",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.37,
        "x": 0.61,
        "y": 0.0011
      },
      "kind": "chart",
      "text": "IFN-gamma secreting cells / 100,000 PBMCs at Baseline, Week 6, and Week 30",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ebc07c22-9a15-47a4-91f7-b547d802572d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.46,
        "x": 0.52,
        "y": 0.0052
      },
      "kind": "chart",
      "text": "SLD of target lesions over time",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5167ecd6-70b3-4d9c-b722-d7a027fae5a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.17,
        "x": 0.35,
        "y": 0.0052
      },
      "kind": "diagram",
      "text": "Treatment timeline: Last Chemo -> PD -> GL-ONC1 Tx -> Partial Response -> Stable Disease",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d4014358-c6a3-41f5-a219-e446135458a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.28,
        "x": 0.04,
        "y": 0.0018
      },
      "kind": "list",
      "text": "Key Takeaways: Off-the-Shelf Personalized Medicine: Single Agent generates Individualized Results. Olvi-Vec induces favorable & long-lasting Tumor-specific T-cell Response (TSTcR)... Documented OR from Olvi-Vec treatment after failure of last chemotherapy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "895c5408-0c21-4b16-9392-d74c108f6e73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.95,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Long-lasting, Tumor-specific T cell response corresponds to tumor reduction",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad3a2424-6206-4970-9f7f-f79991df3ae8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "2207dd0e-5cec-4eaf-8d32-296359c83797",
      "evidence": "The slide contrasts the patient's state before and after Olvi-Vec treatment.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 38,
      "from": 10,
      "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}